Clinical Research, Pharma & Healthcare FinancingPranaX Closes $17M Oversubscribed Series A RoundPR NewswireJanuary 30, 2026February 3, 2026 by PR NewswireJanuary 30, 2026February 3, 2026017 PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series A...
